Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma | Zendy

Hao Wang | Zendy; Han Tang | Zendy; Yong Fang | Zendy; Lijie Tan | Zendy; Jun Yin | Zendy; Yaxing Shen | Zendy; ZhaoChong Zeng | Zendy; Jiangyi Zhu | Zendy; Yingyong Hou | Zendy; Ming Du | Zendy; Jiao Jia | Zendy; Hongjing Jiang | Zendy; Lei Gong | Zendy; Zhigang Li | Zendy; Jun Liu | Zendy; Deyao Xie | Zendy; Wenfeng Li | Zendy; Changhong Lian | Zendy; Qiang Zhao | Zendy; Chun Chen | Zendy; Bin Zheng | Zendy; Yongde Liao | Zendy; Kuo Li | Zendy; Hecheng Li | Zendy; Han Wu | Zendy; Liang Dai | Zendy; KeNeng Chen | Zendy

Open Access

Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Author(s) -

Hao Wang,

Han Tang,

Yong Fang,

Lijie Tan,

Jun Yin,

Yaxing Shen,

ZhaoChong Zeng,

Jiangyi Zhu,

Yingyong Hou,

Ming Du,

Jiao Jia,

Hongjing Jiang,

Lei Gong,

Zhigang Li,

Jun Liu,

Deyao Xie,

Wenfeng Li,

Changhong Lian,

Qiang Zhao,

Chun Chen,

Bin Zheng,

Yongde Liao,

Kuo Li,

Hecheng Li,

Han Wu,

Liang Dai,

KeNeng Chen

Publication year - 2021

Publication title -

jama surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.757

H-Index - 176

eISSN - 2168-6262

pISSN - 2168-6254

DOI - 10.1001/jamasurg.2021.0133

Subject(s) - medicine , neoadjuvant therapy , esophagectomy , chemotherapy , chemoradiotherapy , radiation therapy , surgery , randomized controlled trial , oncology , esophageal cancer , cancer , breast cancer

Safety and efficacy of neoadjuvant chemoradiotherapy (nCRT) vs neoadjuvant chemotherapy (nCT) for treatment of locally advanced esophageal squamous cell carcinoma (ESCC) remain uncertain given lack of high-level clinical evidence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research